Analyze Diet
Reproduction in domestic animals = Zuchthygiene2022; 57 Suppl 4(Suppl 4); 4-12; doi: 10.1111/rda.14129

Suppression of reproductive behaviour and gonadal function in female horses-An update.

Abstract: The behaviour of mares is often detrimental to their performance resulting in frequent demand for methods to suppress gonadal function. In addition, prevention of unintended reproduction especially in feral horse populations may require methods for suppression of gonadal function. Surgical ovariectomy is a safe method but not an acceptable approach in feral mares and undesired in mares where future breeding is considered. There are different approaches for artificial prolongation of the luteal phase resulting in transient inhibition of oestrus and ovulation. Among those, treatment with natural or synthetic progestogens is considered the most common and successful method. Whereas application of intrauterine devices may result in prolongation of luteal function in non-pregnant mares, intrauterine insertion of glass balls is no longer recommended because of complications in individual mares. There are several safer alternatives that may be of interest, especially for population control in free-roaming horses. Treatment with long-acting deslorelin implants inhibited ovulation and oestrus behaviour in mares for limited and variable time intervals in a dose-dependent manner. The effect of GnRH vaccines varies considerably among individual mares, is age dependent, and oestrus-like behaviour may still occur. Contraception via immunization against native porcine or recombinant zona pellucida antigen is successful, but immunocontraception is as much a result of ovarian inactivity as an antibody-based block to sperm-oocyte binding. In conclusion, several treatments for suppression of gonadal function in mares are available, but there are advantages and disadvantages associated that have to be considered. The treatment of choice will thus differ with regard to the demands.
Publication Date: 2022-05-01 PubMed ID: 35467049PubMed Central: PMC9790428DOI: 10.1111/rda.14129Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The paper discusses various methods used to control reproduction and sexual behavior in female horses, highlighting the benefits and drawbacks associated with each approach.

Methods of Suppressing Gonadal Function

  • The study explores the need to suppress gonadal function in mares to prevent unintended breeding, particularly in cases of feral horses. This is often necessitated by the fact that sometimes, the intense behaviour of mares can affect their performance adversely.
  • Surgical ovariectomy (removal of ovaries) is one commonly used method. However, this is not suitable for all cases particularly feral mares or mares where future breeding is a consideration.

Prolongation of the Luteal Phase

  • The research outlines various approaches to artificially prolong the luteal phase, a part of a mare’s cycle during which pregnancy can occur, for providing transient inhibition of oestrus (a period when the mare is in heat) and ovulation.
  • These treatments include the use of both natural and synthetic progestogens (a type of hormone), which have been found to be particularly effective.

Use of Intrauterine Devices

  • Intrauterine devices are another option mentioned in the research. Nonetheless, the study advises against using certain types of such devices, like glass balls insertion due to related complications that have been historically experienced.

Alternative Treatments

  • The document proposes safer alternatives for population control in free-roaming horses. These include the use of deslorelin implants that provide dose-dependent control of ovulation and oestrus behaviour.
  • Another method discussed is the use of Gonadotropin-Releasing Hormone (GnRH) vaccines but their effects vary largely between individual mares and are also dependent on the mare’s age.

Contraception via Immunization

  • The research also mentions vaccination-based contraception methods, where immunization against native porcine or recombinant zona pellucida antigen has proven successful.
  • However, it was voiced that immunocontraception also leads to ovarian inactivity, which may serve as an additional contraceptive mechanism by blocking sperm-oocyte binding.

Conclusion

  • Overall, the study concludes that various treatments exist for controlling reproductive behaviour and gonadal function in female horses, each bringing its own advantages and challenges.
  • The choice of method would subsequently depend on specific demands and needs, and these factors must be appropriately weighed before making a decision.

Cite This Article

APA
Aurich C, Kaps M. (2022). Suppression of reproductive behaviour and gonadal function in female horses-An update. Reprod Domest Anim, 57 Suppl 4(Suppl 4), 4-12. https://doi.org/10.1111/rda.14129

Publication

ISSN: 1439-0531
NlmUniqueID: 9015668
Country: Germany
Language: English
Volume: 57 Suppl 4
Issue: Suppl 4
Pages: 4-12

Researcher Affiliations

Aurich, Christine
  • Artificial Insemination and Embryo Transfer, Department for Small Animals and Horses, Vetmeduni Vienna, Vienna, Austria.
Kaps, Martim
  • Artificial Insemination and Embryo Transfer, Department for Small Animals and Horses, Vetmeduni Vienna, Vienna, Austria.

MeSH Terms

  • Animals
  • Contraception, Immunologic / veterinary
  • Female
  • Gonadotropin-Releasing Hormone / pharmacology
  • Horses
  • Male
  • Ovulation
  • Reproductive Behavior
  • Semen
  • Swine

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 90 references
  1. Allen WR, Rossdale PD. A preliminary study upon the use of prostaglandins for inducing oestrus in non-cycling thoroughbred mares.. Equine Vet J 1973 Oct;5(4):137-40.
  2. Argo CM, Turnbull EB. The effect of intra-uterine devices on the reproductive physiology and behaviour of pony mares.. Vet J 2010 Oct;186(1):39-46.
    doi: 10.1016/j.tvjl.2009.07.013pubmed: 19709909google scholar: lookup
  3. Asa CS, Goldfoot DA, Garcia MC, Ginther OJ. Sexual behavior in ovariectomized and seasonally anovulatory pony mares (Equus caballus).. Horm Behav 1980 Mar;14(1):46-54.
    doi: 10.1016/0018-506X(80)90014-8pubmed: 7190538google scholar: lookup
  4. Asa CS. Sexual behavior of mares.. Vet Clin North Am Equine Pract 1986 Dec;2(3):519-34.
    pubmed: 3492243doi: 10.1016/s0749-0739(17)30704-6google scholar: lookup
  5. Aurich C, Daels PF, Ball BA, Aurich JE. Effects of gonadal steroids on the opioid regulation of LH and prolactin release in ovariectomized pony mares.. J Endocrinol 1995 Nov;147(2):195-202.
    pubmed: 7490548doi: 10.1677/joe.0.1470195google scholar: lookup
  6. Barber MR, Fayrer-Hosken RA. Possible mechanisms of mammalian immunocontraception.. J Reprod Immunol 2000 Mar;46(2):103-24.
    doi: 10.1016/S0165-0378(99)00063-7pubmed: 10706942google scholar: lookup
  7. Bradley MP, Eade J, Penhale J, Bird P. Vaccines for fertility regulation of wild and domestic species.. J Biotechnol 1999 Aug 20;73(2-3):91-101.
    doi: 10.1016/S0168-1656(99)00112-1pubmed: 10486919google scholar: lookup
  8. nBritish Horserace Authorityn(2018). BHA NOTICE – REGUMATE EQUINE. Retrieved from https://www.britishhorseracing.com/wp‐content/uploads/2018/09/BHA‐Notice‐Regumate‐200918.pdfn
  9. Burger D, Wohlfender F, Imboden I. Managing a mare for breeding and sport. Pferdeheilkunde 24, 102–107.
    doi: 10.21836/PEM20080122google scholar: lookup
  10. Cox JH, DeBowes RM. Colic-like discomfort associated with ovulation in two mares.. J Am Vet Med Assoc 1987 Dec 1;191(11):1451-2.
    pubmed: 3692993
  11. Crowell-Davis SL. Sexual behavior of mares.. Horm Behav 2007 Jun;52(1):12-7.
    pubmed: 17488645doi: 10.1016/j.yhbeh.2007.03.020google scholar: lookup
  12. Cuervo-Arango J, Claes AN, Stout TAE. Mare and stallion effects on blastocyst production in a commercial equine ovum pick-up-intracytoplasmic sperm injection program.. Reprod Fertil Dev 2019 Jan;31(12):1894-1903.
    doi: 10.1071/RD19201pubmed: 31634435google scholar: lookup
  13. Daels PF, Hughes JP. Fertility control using intrauterine devices: an alternative for population control in wild horses.. Theriogenology 1995 Oct;44(5):629-39.
    doi: 10.1016/0093-691X(95)00243-2pubmed: 16727761google scholar: lookup
  14. Daels PF, McCue PM, DeMoraes MJ, Hughes JP. Persistence of the luteal phase following ovulation during altrenogest treatment in mares.. Theriogenology 1996 Oct 1;46(5):799-811.
    doi: 10.1016/S0093-691X(96)00238-5pubmed: 16727944google scholar: lookup
  15. Dalin AM, Andresen O, Malmgren L. Immunization against gnRH in mature mares: antibody titres, ovarian function, hormonal levels and oestrous behaviour.. J Vet Med A Physiol Pathol Clin Med 2002 Apr;49(3):125-31.
  16. de Amorim MD, Chenier T, Nairn D, Green J, Manning S, Card C. Complications associated with intrauterine glass marbles in five mares.. J Am Vet Med Assoc 2016 Nov 15;249(10):1196-1201.
    doi: 10.2460/javma.249.10.1196pubmed: 27823367google scholar: lookup
  17. Elhay M, Newbold A, Britton A, Turley P, Dowsett K, Walker J. Suppression of behavioural and physiological oestrus in the mare by vaccination against GnRH.. Aust Vet J 2007 Jan-Feb;85(1-2):39-45.
  18. Farquhar VJ, McCue PM, Carnevale EM, Nett TM, Squires EL. Deslorelin acetate (Ovuplant) therapy in cycling mares: effect of implant removal on FSH secretion and ovarian function.. Equine Vet J 2002 Jul;34(4):417-20.
    doi: 10.2746/042516402776249227pubmed: 12117117google scholar: lookup
  19. Farquhar VJ, McCue PM, Nett TM, Squires EL. Effect of deslorelin acetate on gonadotropin secretion and ovarian follicle development in cycling mares.. J Am Vet Med Assoc 2001 Mar 1;218(5):749-52.
    doi: 10.2460/javma.2001.218.749pubmed: 11280410google scholar: lookup
  20. Fayrer-Hosken R. Controlling animal populations using anti-fertility vaccines.. Reprod Domest Anim 2008 Jul;43 Suppl 2:179-85.
  21. Fedorka CE, Ball BA, Walker OF, Conley AJ, Corbin CJ, Lu KG, Hanneman JM, Troedsson MHT, Adams AA. Alteration of the mare's immune system by the synthetic progestin, altrenogest.. Am J Reprod Immunol 2019 Aug;82(2):e13145.
    doi: 10.1111/aji.13145pubmed: 31087434google scholar: lookup
  22. Freeman C E, Lyle S K. Chronic intermittent colic in a mare attributed to uterine marbles. Equine Veterinary Education 27, 469–473.
    doi: 10.1111/eve.12408google scholar: lookup
  23. Garcia MC, Freedman LJ, Ginther OJ. Interaction of seasonal and ovarian factors in the regulation of LH and FSH secretion in the mare.. J Reprod Fertil Suppl 1979;(27):103-11.
    pubmed: 289780
  24. Garcia MC, Ginther OJ. Regulation of plasma LH by estradiol and progesterone in ovariectomized mares.. Biol Reprod 1978 Sep;19(2):447-53.
    pubmed: 719099doi: 10.1095/biolreprod19.2.447google scholar: lookup
  25. Garza F Jr, Thompson DL Jr, French DD, Wiest JJ, St George RL, Ashley KB, Jones LS, Mitchell PS, McNeill DR. Active immunization of intact mares against gonadotropin-releasing hormone: differential effects on secretion of luteinizing hormone and follicle-stimulating hormone.. Biol Reprod 1986 Sep;35(2):347-52.
    doi: 10.1095/biolreprod35.2.347pubmed: 3094596google scholar: lookup
  26. Gautier C, Schmidt K, Aurich J, Aurich C. Effects of implants containing the GnRH agonist deslorelin on testosterone release and semen characteristics in Shetland stallions.. Anim Reprod Sci 2018 Aug;195:230-241.
  27. Ginther OJ. Prolonged luteal activity in mares--a semantic quagmire.. Equine Vet J 1990 May;22(3):152-6.
  28. Glazar BS, McCue PM, Bruemmer JE, Squires EL. Deslorelin on Day 8 or 12 postovulation does not luteinize follicles during an artificially maintained diestrous phase in the mare.. Theriogenology 2004 Jul;62(1-2):57-64.
  29. Gradil CM, Uricchio CK, Schwarz A. Self-Assembling Intrauterine Device (Upod) Modulation of the Reproductive Cycle in Mares.. J Equine Vet Sci 2019 Dec;83:102690.
    doi: 10.1016/j.jevs.2019.02.009pubmed: 31791523google scholar: lookup
  30. Hedberg Y, Dalin AM, Forsberg M, Lundeheim N, Hoffmann B, Ludwig C, Kindahl H. Effect of ACTH (tetracosactide) on steroid hormone levels in the mare. Part A: effect in intact normal mares and mares with possible estrous related behavioral abnormalities.. Anim Reprod Sci 2007 Jul;100(1-2):73-91.
  31. Hedberg Y, Dalin AM, Forsberg M, Lundeheim N, Sandh G, Hoffmann B, Ludwig C, Kindahl H. Effect of ACTH (tetracosactide) on steroid hormone levels in the mare. Part B: effect in ovariectomized mares (including estrous behavior).. Anim Reprod Sci 2007 Jul;100(1-2):92-106.
  32. Hedberg Y, Dalin AM, Santesson M, Kindahl H. A preliminary study on the induction of dioestrous ovulation in the mare--a possible method for inducing prolonged luteal phase.. Acta Vet Scand 2006 Jul 26;48(1):12.
    doi: 10.1186/1751-0147-48-12pmc: PMC1557516pubmed: 16987391google scholar: lookup
  33. Hershman L, Douglas RH. The critical period for the maternal recognition of pregnancy in pony mares.. J Reprod Fertil Suppl 1979;(27):395-401.
    pubmed: 289816
  34. Hobbs R J, Hinds L A. Could current fertility control methods be effective for landscape‐scale management of populations of wild horses (Equus caballus) in Australia. Wildlife Research 45, 195–207.
    doi: 10.1071/WR17136google scholar: lookup
  35. Holyoak G R, Lyman C C, Wang S, Germaine S S, Anderson C O, Baldrighi J M, Vemula N, Rezabek G B, Kane A J. Efficacy of a Y‐design silastic elastomer intrauterine device as a horse contraceptive. The Journal of Wildlife Management 85, 1169–1174.
    doi: 10.1002/jwmg.22027google scholar: lookup
  36. Hooper RN, Taylor TS, Varner DD, Blanchard TL. Effects of bilateral ovariectomy via colpotomy in mares: 23 cases (1984-1990).. J Am Vet Med Assoc 1993 Oct 1;203(7):1043-6.
    pubmed: 8226251
  37. Hoopes KH, Gradil CM, Vanderwall DK, Mason HM, Sarnecky BA, Davies CJ. Preliminary study of the contraceptive effect of a self-assembling intrauterine device (iUPODs) in mares maintained in a paddock with a fertile stallion.. Anim Reprod Sci 2021 Dec;235:106881.
  38. Imboden I, Janett F, Burger D, Crowe MA, Hässig M, Thun R. Influence of immunization against GnRH on reproductive cyclicity and estrous behavior in the mare.. Theriogenology 2006 Nov;66(8):1866-75.
  39. nInternational Equestrian Federation (FEI)n(2022). Equine prohibited substance list 2022. Retrieved from https://inside.fei.org/sites/default/files/2022%20Prohibited%20Substances%20List.pdfn
  40. nInternational Federation of Horserace Authorities (IFHA)n(2021). International Agreement on Breeding, Racing and Wagering and Appendixes, Article 6. Retrieved from https://www.ifhaonline.org/resources/ifAgreement.pdfn
  41. Johnson C A, Thompson D L, Kulinski K M, Guitreau A M. Prolonged interovulatory interval and hormonal changes in mares following the use of Ovuplant™ to hasten ovulation. Journal of Equine Veterinary Science 20, 331–336.
  42. Joonè CJ, Bertschinger HJ, Gupta SK, Fosgate GT, Arukha AP, Minhas V, Dieterman E, Schulman ML. Ovarian function and pregnancy outcome in pony mares following immunocontraception with native and recombinant porcine zona pellucida vaccines.. Equine Vet J 2017 Mar;49(2):189-195.
    doi: 10.1111/evj.12557pubmed: 26708619google scholar: lookup
  43. Joonè CJ, Gradil CM, Picard JA, Taylor JD, de Tonnerre D, Cavalieri J. The contraceptive efficacy of a self-assembling intra-uterine device in domestic mares.. Aust Vet J 2021 Apr;99(4):130-136.
    doi: 10.1111/avj.13055pubmed: 33462802google scholar: lookup
  44. Joonè CJ, Nolan MB, Bertschinger HJ, Schulman ML. Researching immunocontraceptive vaccines with mares (Equus caballus) as both a target and model for African elephant (Loxodonta africana) cows: A review.. Anim Reprod Sci 2019 Aug;207:146-152.
  45. Joonè CJ, Schulman ML, Bertschinger HJ. Ovarian dysfunction associated with zona pellucida-based immunocontraceptive vaccines.. Theriogenology 2017 Feb;89:329-337.
  46. Kaps M, Lutzer A, Gautier C, Nagel C, Aurich J, Aurich C. Altrenogest treatment reduces the stress response of three-year-old warmblood mares during their initial equestrian training.. Domest Anim Endocrinol 2022 Jul;80:106728.
  47. Kaps M, Okada CTC, Gautier CM, Aurich J, Aurich C. Deslorelin Slow-Release Implants Delay Ovulation and Increase Plasma AMH Concentration and Small Antral Follicles in Haflinger Mares.. Animals (Basel) 2021 May 28;11(6).
    doi: 10.3390/ani11061600pmc: PMC8229780pubmed: 34071625google scholar: lookup
  48. Kaps M, Okada CTC, Gautier C, Aurich J, Scarlet D, Kuhl J, Aurich C. Transient suppression of ovulatory ovarian function in pony mares after treatment with slow-release deslorelin implants.. Domest Anim Endocrinol 2021 Jan;74:106505.
  49. Katila T. Clinical commentary: Techniques to suppress oestrus in mares. Equine Veterinary Education 27, 344–345.
    doi: 10.1111/eve.12324google scholar: lookup
  50. Keith L, Ball BA, Scoggin K, Esteller-Vico A, Woodward EM, Troedsson MH, Squires EL. Diestrus administration of oxytocin prolongs luteal maintenance and reduces plasma PGFM concentrations and endometrial COX-2 expression in mares.. Theriogenology 2013 Mar 1;79(4):616-24.
  51. Kirkpatrick JF, Rowan A, Lamberski N, Wallace R, Frank K, Lyda R. The practical side of immunocontraception: zona proteins and wildlife.. J Reprod Immunol 2009 Dec;83(1-2):151-7.
    doi: 10.1016/j.jri.2009.06.257pubmed: 19850355google scholar: lookup
  52. Laconi MR, Casteller G, Gargiulo PA, Bregonzio C, Cabrera RJ. The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats.. Eur J Pharmacol 2001 Apr 6;417(1-2):111-6.
    doi: 10.1016/S0014-2999(01)00865-2pubmed: 11301065google scholar: lookup
  53. Lefranc AC, Allen WR. Nonpharmacological suppression of oestrus in the mare.. Equine Vet J 2004 Mar;36(2):183-5.
    doi: 10.2746/0425164044868675pubmed: 15043003google scholar: lookup
  54. Liu IK, Bernoco M, Feldman M. Contraception in mares heteroimmunized with pig zonae pellucidae.. J Reprod Fertil 1989 Jan;85(1):19-29.
    doi: 10.1530/jrf.0.0850019pubmed: 2915353google scholar: lookup
  55. Lofstedt RM, Patel JH. Evaluation of the ability of altrenogest to control the equine estrous cycle.. J Am Vet Med Assoc 1989 Feb 1;194(3):361-4.
    pubmed: 2645256
  56. Loy RG, Swan SM. Effects of exogenous progestogens on reproductive phenomena in mares.. J Anim Sci 1966 Aug;25(3):821-6.
    doi: 10.2527/jas1966.253821xpubmed: 5968673google scholar: lookup
  57. Lyman CC, Baldrighi JM, Anderson CO, Germaine SS, Kane AJ, Holyoak GR. Modification of O-ring intrauterine devices (IUDs) in mares: Contraception without estrus suppression.. Anim Reprod Sci 2021 Nov;234:106864.
  58. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.. Science 1986 May 23;232(4753):1004-7.
    doi: 10.1126/science.2422758pubmed: 2422758google scholar: lookup
  59. Martínez-Mota L, Contreras CM, Saavedra M. Progesterone reduces immobility in rats forced to swim.. Arch Med Res 1999 Jul-Aug;30(4):286-9.
    doi: 10.1016/S0188-0128(99)00024-Xpubmed: 10573629google scholar: lookup
  60. McConaghy FF, Green LA, Colgan S, Morris LH. Studies of the pharmacokinetic profile, in vivo efficacy and safety of injectable altrenogest for the suppression of oestrus in mares.. Aust Vet J 2016 Jul;94(7):248-55.
    doi: 10.1111/avj.12459pubmed: 27349885google scholar: lookup
  61. McCue P M. Estrus suppression in performance horses. Journal of Equine Veterinary Science 23, 342–344.
  62. McCue PM. Hormone Therapy in Clinical Equine Practice.. Vet Clin North Am Equine Pract 2016 Dec;32(3):425-434.
    doi: 10.1016/j.cveq.2016.07.001pubmed: 27810035google scholar: lookup
  63. McCue PM, Farquhar VJ, Carnevale EM, Squires EL. Removal of deslorelin (Ovuplant) implant 48 h after administration results in normal interovulatory intervals in mares.. Theriogenology 2002 Sep;58(5):865-70.
    doi: 10.1016/S0093-691X(02)00923-8pubmed: 12212887google scholar: lookup
  64. McKinnon AO, Lescun TB, Walker JH, Vasey JR, Allen WR. The inability of some synthetic progestagens to maintain pregnancy in the mare.. Equine Vet J 2000 Jan;32(1):83-5.
    doi: 10.2746/042516400777612035pubmed: 10661391google scholar: lookup
  65. Morris L H, Fraser B S, Cantley C, Wilsher S. The hazards associated with the use of intrauterine glass balls to suppress oestrus in mares. Equine Veterinary Education 29, 125e30.
    doi: 10.1111/eve.12600google scholar: lookup
  66. Newcombe J R. The incidence of ovulation during the luteal phase from day 4 to day 20 in pregnant and non pregnant mares. Journal of Equine Veterinary Science 17, 120–122.
  67. Nie G J, Johnson K E, Braden T D, Wenzel J G W. Use of an intra‐uterine glass ball protocol to extend luteal function in mares. Journal of Equine Veterinary Science 23, 266–273.
    doi: 10.1053/jevs.2003.75google scholar: lookup
  68. Nolan MB, Bertschinger HJ, Roth R, Crampton M, Martins IS, Fosgate GT, Stout TA, Schulman ML. Ovarian function following immunocontraceptive vaccination of mares using native porcine and recombinant zona pellucida vaccines formulated with a non-Freund's adjuvant and anti-GnRH vaccines.. Theriogenology 2018 Oct 15;120:111-116.
  69. Nolan MB, Schulman ML, Botha AE, Human AM, Roth R, Crampton MC, Bertschinger HJ. Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund's adjuvant in horses.. Vaccine 2019 Feb 28;37(10):1299-1306.
    doi: 10.1016/j.vaccine.2019.01.053pubmed: 30733089google scholar: lookup
  70. Palmer SE. Standing laparoscopic laser technique for ovariectomy in five mares.. J Am Vet Med Assoc 1993 Jul 15;203(2):279-83.
    pubmed: 8407491
  71. Parkinson KC, Vanderwall DK, Rigas J, Sweat A. Effect of Chronic Administration of Oxytocin on Corpus Luteum Function in Cycling Mares.. J Equine Vet Sci 2020 Jul;90:102991.
    doi: 10.1016/j.jevs.2020.102991pubmed: 32534769google scholar: lookup
  72. Picazo O, Fernández-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test.. Brain Res 1995 May 22;680(1-2):135-41.
    doi: 10.1016/0006-8993(95)00254-Npubmed: 7663969google scholar: lookup
  73. Pryor P, Tibary A. Management of estrus in the performance mare. Clinical Techniques in Equine Practice 4, 197–209.
  74. Rivera Del Alamo MM, Katila T, Palviainen M, Reilas T. Effects of intrauterine devices on proteins in the uterine lavage fluid of mares.. Theriogenology 2021 Apr 15;165:1-9.
  75. Rivera Del Alamo MM, Reilas T, Kindahl H, Katila T. Mechanisms behind intrauterine device-induced luteal persistence in mares.. Anim Reprod Sci 2008 Aug;107(1-2):94-106.
  76. Röcken M, Mosel G, Seyrek-Intas K, Seyrek-Intas D, Litzke F, Verver J, Rijkenhuizen AB. Unilateral and bilateral laparoscopic ovariectomy in 157 mares: a retrospective multicenter study.. Vet Surg 2011 Dec;40(8):1009-14.
  77. Roessner H A, Kurtz K A, Caron J P. Laparoscopic ovariectomy diminishes estrus‐associated behavioral problems in mares. Journal of Equine Veterinary Science 35, 250–253.
  78. Schulman ML, Botha AE, Muenscher SB, Annandale CH, Guthrie AJ, Bertschinger HJ. Reversibility of the effects of GnRH-vaccination used to suppress reproductive function in mares.. Equine Vet J 2013 Jan;45(1):111-3.
  79. Squires EL, Heesemann CP, Webel SK, Shideler RK, Voss JL. Relationship of altrenogest to ovarian activity, hormone concentrations and fertility of mares.. J Anim Sci 1983 Apr;56(4):901-10.
    pubmed: 6406416doi: 10.2527/jas1983.564901xgoogle scholar: lookup
  80. Squires EL, Stevens WB, McGlothlin DE, Pickett BW. Effect of an oral progestin on the estrous cycle and fertility of mares.. J Anim Sci 1979 Sep;49(3):729-35.
    pubmed: 528432doi: 10.2527/jas1979.493729xgoogle scholar: lookup
  81. Stabenfeldt GH, Hughes JP, Evans JW, Neely DP. Spontaneous prolongation of luteal activity in the mare.. Equine Vet J 1974 Oct;6(4):158-63.
  82. Storer W A, Thompson D L, Gilley R M, Burns P J. Evaluation of injectable sustained release progestin formulations for suppression of estrus and ovulation in mares. Journal of Equine Veterinary Science 29, 33–36.
  83. Stout TA, Colenbrander B. Suppressing reproductive activity in horses using GnRH vaccines, antagonists or agonists.. Anim Reprod Sci 2004 Jul;82-83:633-43.
  84. Swegen A, Aitken RJ. Prospects for immunocontraception in feral horse population control: exploring novel targets for an equine fertility vaccine.. Reprod Fertil Dev 2016 Jun;28(7):853-863.
    doi: 10.1071/RD14280pubmed: 25482876google scholar: lookup
  85. Tshewang U, Dowsett KF, Knott LM, Trigg TE. Preliminary study of ovarian activity in fillies treated with a GnRH vaccine.. Aust Vet J 1997 Sep;75(9):663-7.
  86. Turner R M, Vanderwall D K, Stawicki R. Complications associated with the presence of two intrauterine glass balls used for oestrus suppression in a mare. Equine Veterinary Education 27, 340–343.
    doi: 10.1111/eve.12311google scholar: lookup
  87. nU.S. Food and Drug Administration. FDA Animal Drug Safety Communicationn(2019). FDA highlights potential health risks to people exposed to altrenogest products for horses or pigs. [November 05, 2019]; Retrieved from https://www.fda.gov/animal‐veterinary/cvm‐updates/fda‐animal‐drug‐safety‐communication‐fda‐highlights‐potential‐health‐risks‐people‐exposedn
  88. Vanderwall DK. Is it time to retire the use of intrauterine glass balls for estrus suppression in mares?. J Am Vet Med Assoc 2015 Aug 15;247(4):346-7.
    doi: 10.2460/javma.247.4.346pubmed: 26225603google scholar: lookup
  89. Vanderwall D K, Parkinson K C, Rigas J. How to use oxytocin treatment to prolong corpus luteum function for suppressing estrus in mares. Journal of Equine Veterinary Science 36, 1–4.
  90. Vanderwall D K, Rasmussen D M, Carnahan K G, Davis T L. Effect of administration of oxytocin during diestrus on corpus luteum function and endometrial oxytocin receptor concentration in cycling mares. Journal of Equine Veterinary Science 32, 536–541.

Citations

This article has been cited 2 times.
  1. Wolf N, Hahn JA, Walter I, Zablotski Y, Zerbe H, Witte TS. Pathohistological Findings after Bilateral Ovariectomy in Mares with Behavioral Problems. Animals (Basel) 2024 Oct 8;14(19).
    doi: 10.3390/ani14192899pubmed: 39409848google scholar: lookup
  2. Straticò P, Hattab J, Guerri G, Carluccio A, Bandera L, Celani G, Marruchella G, Varasano V, Petrizzi L. Behavioral Disorders in Mares with Ovarian Disorders, Outcome after Laparoscopic Ovariectomy: A Case Series. Vet Sci 2023 Jul 25;10(8).
    doi: 10.3390/vetsci10080483pubmed: 37624270google scholar: lookup